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Background: There is limited data on the impact of very low left ventricular ejection fraction (LVEF) on mortality after catheter ablation of 
ventricular tachycardia (VT).
Methods: Multicenter, retrospective analysis of all consecutive patients undergoing VT ablation at 4 high volume centers between 2007 and 2010. 
We evaluated the baseline characteristics, indications, procedural variables and outcomes after VT ablation. We evaluated the impact of low and very 
low LVEF and other known predictors of mortality at long term follow up.
Results: 172 patients were included in the final analysis. Mean age was 63 years with 87% being males. Mean LVEF was 38 and mean QRS 
duration was 123msec. After mean follow-up of 24months, 37 (22%) died. In univariate analysis the predictors of mortality were age (p<0.001), 
non-ischemic cardiomyopathy (p=0.017), COPD (p<0.001), chronic renal insufficiency (p<0.001), wider QRS duration (p<0.001) and worse LVEF 
(p<0.001). Mortality in patients with LVEF ≤20, 21-35 and ≥36 were 45%, 22% and 13% respectively (p=0.002). In multivariate regression analysis 
the age, COPD and severely impaired LVEF were independence predictors of mortality.
Conclusions: There is a graded increase in mortality with worsening LVEF in patients undergoing VT ablation irrespective of the success.
Table: Predictors of mortality after VT ablation 
Clinical Variables
Dead during follow up 
(n = 37)
Alive at the end of follow up (n = 135) Total (n = 172) p value
Age in years (mean) 71.7 50.0 62.6 <0.001
Male Sex (%) 31 (84) 118 (87) 149 (87) 0.566
Ischemic Cardiomyopathy (%) 20 (54) 80 (59) 100 (58) 0.323
Non-Ischemic Cardiomyopathy (%) 13 (35) 22 (16) 35 (20) 0.017
Hypertension (%) 26 (70) 79 (59) 105 (61) 0.194
Diabetes Mellitus (%) 12 (32) 29 (22) 41 (24) 0.166
Chronic obstructive pulmonary disease (%) 14 (38) 13 (10) 27 (16) <0.001
Chronic renal insufficiency (%) 16 (43) 15 (11) 31 (18) <0.001
Coronary artery disease (%) 28 (76) 89 (67) 117 (68) 0.260
Hyperlipidemia(%) 24 (65) 69 (51) 93 (54) 0.137
Beta Blockers (%) 32 (94) 108 (86) 140 (88) 0.217
ACEi/ARB (%) 25 (67) 80 (59) 105 (61) 0.447
Atrial Fibrillation (%) 12 (32) 27 (20) 39 (22) 0.122
Successful VT ablation 31 (86) 124 (91) 155 (90) 0.212
LVEF mean 30 39 37 <0.001
LVEF Groups 0.002
≤20 13 (35) 16 (12) 29 (17)
21-35 14 (39) 51 (39) 65 (38)
≥36 10 (27) 68 (50) 78 (45)
QRSD mean in msec 142 118 123 <0.001
